Donald E. Stout - 05 Jan 2023 Form 4/A - Amendment Insider Report for XWELL, Inc. (XWEL)

Reporting relationship: Director
Issuer ticker: XWEL
Reported as of: 05 Jan 2023
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 09 Jan 2023, 20:36:48 UTC
Original report date: 09 Jan 2023
Prior SEC filing: 31 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Cara Soffer, Attorney-in-Fact for Donald E. Stout

Key filing fact

Donald E. Stout filed Form 4/A - Amendment for XWELL, Inc. (XWEL) on 09 Jan 2023.

Key facts

This page summarizes Donald E. Stout's Form 4/A - Amendment filing for XWELL, Inc. (XWEL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jan 2023, 20:36.

Change

Previous filing in this sequence was filed on 31 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XWEL transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +300,000
Change %
Price: $0.000000
Shares after: 300,000
Date: 05 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 300,000
Exercise price: $0.4000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This grant is pursuant to the directors compensation plan.

Footnote F2

The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023.

SEC remarks

This amendment is being filed to correct the exercise price for the stock option grant and to revise the text of footnote 1.